Forte Biosciences (FBRX) Convertible Debt (2016 - 2017)
Forte Biosciences (FBRX) has disclosed Convertible Debt for 2 consecutive years, with $11.0 million as the latest value for Q1 2017.
- Quarterly Convertible Debt changed N/A to $11.0 million in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $11.0 million through Mar 2017, changed N/A year-over-year, with the annual reading at $3.4 million for FY2016, N/A changed from the prior year.
- Convertible Debt for Q1 2017 was $11.0 million at Forte Biosciences, up from $3.4 million in the prior quarter.
- The five-year high for Convertible Debt was $11.0 million in Q1 2017, with the low at $3.4 million in Q4 2016.